<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="135971">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01331369</url>
  </required_header>
  <id_info>
    <org_study_id>FURB 2010/01</org_study_id>
    <nct_id>NCT01331369</nct_id>
  </id_info>
  <brief_title>Intensification of Care to Improve Adherence to Anti-hypertensives</brief_title>
  <acronym>HyperCare</acronym>
  <official_title>Intensification of Care to Improve Adherence to Anti-hypertensives in Primary Care: a Pragmatic Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade de Blumenau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacao de Apoio a Pesquisa de Santa Catarina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade de Blumenau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effectiveness of a social-psychological intervention
      to improve anti-hypertensives adherence in primary care. Its is a pragmatic clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will study two groups of 198 people with hypertension treated in ten health care units.
      One group will receive usual care dispensed in units (control). The other group
      (intervention) will be offered six individual assistance with health care worker physician
      or nurse) during the period of 9 months with a minimum interval of 30 days, plus 9 monthly
      visits structured by community health agents. Adherence will be measured in both groups at
      baseline and months 3, 6, 9 and 12, through validated questionnaire and pill count. Also
      evaluated clinical outcome measures (blood pressure, hospitalizations and deaths). The
      analysis will be done by intention to treat comparing adherence measures and clinical
      outcome between groups (Student t test and chi-square test) and within groups over time
      (paired t test and McNemar). It will be accepted p value &lt;0.05.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Means difference and risk ratio between and within groups of adherence to treatment</measure>
    <time_frame>at basal and 3, 6, 9 and 12 months</time_frame>
    <description>It will be evaluated by two methods: pill count (proportion of pill taken as prescribed) and self-report using a structured validated questionnaire (proportion adherents in each group).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Means difference and/or risk ratio between and within groups of clinical outcomes</measure>
    <time_frame>at basal and 3, 6, 9 and 12 months</time_frame>
    <description>It will be evaluated mean blood pressure, proportion of complications, hospitalization and death in each group.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">396</enrollment>
  <condition>Medication Adherence</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual provided care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Social-psychological interventions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensification of Care</intervention_name>
    <description>Usual provided care plus social-psychological intervention: 6 consultation with doctors and 9 with community health workers, both oriented by protocol.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Comprehensive Care</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Usual care provided (medical and/or nurse consultation and medicines)</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Usual</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  persons with hypertension aged 18 years and older

        Exclusion Criteria:

          -  those with physical or mental impaired that cannot go to health care units or cannot
             answer a questionnaire

          -  pregnants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ernani S Helena, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regional University of Blumenau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ernani S Helena, PhD</last_name>
    <phone>55 47 3321 0610</phone>
    <email>erntsh@furb.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nevoni G Damo, MSc</last_name>
    <phone>55 47 3321 0610</phone>
    <email>nevoni@furb.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Family Health Units - Unique Health System</name>
      <address>
        <city>Blumenau</city>
        <state>Santa Catarina</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheila Santos, MSc</last_name>
      <email>gerenciafarmaceutica@blumenau.sc.gov.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <lastchanged_date>April 7, 2011</lastchanged_date>
  <firstreceived_date>March 29, 2011</firstreceived_date>
  <responsible_party>
    <name_title>Ernani Tiaraju de Santa Helena</name_title>
    <organization>Universidade Regional de Blumenau</organization>
  </responsible_party>
  <keyword>adherence</keyword>
  <keyword>compliance</keyword>
  <keyword>persistence</keyword>
  <keyword>drop out</keyword>
  <keyword>abandon</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
